Lucira Health to Participate in Bank of America 2022 Healthcare Conference

Rhea-AI Summary

Lucira Health, a medical technology company, will present at the Bank of America 2022 Healthcare Conference on May 11, 2022, at 11:00 PM ET. The event can be accessed via a live and archived webcast on Lucira's website. Known for its innovative infectious disease test kits, Lucira focuses on providing lab-quality molecular testing in a user-friendly, portable format. The company is also developing new diagnostic tests, including a combined test for COVID-19 and Flu. Visit www.lucirahealth.com for more details.

News Market Reaction – LHDX

+1.97%

+1.97% Session move

In the trading session that priced this news, LHDX gained 1.97%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in the Bank of America 2022 Healthcare Conference on May 11th, 2022, at 11:00pm ET.

Lucira’s management is scheduled to present at the Bank of America 2022 Healthcare Conference on May 11th, 2022, at 11:00pm ET. A live and archived webcast of the event can be accessed through the Events and Presentations page of the Lucira website.

About Lucira Health
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time.

Beyond its COVID-19 tests, Lucira is working on new diagnostic tests including a single test for COVID-19 & Flu as well as other infectious diseases. For more information, visit www.lucirahealth.com.

Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
332-895-3230

FAQ

When will Lucira Health present at the Bank of America Healthcare Conference?

Lucira Health will present on May 11, 2022, at 11:00 PM ET.

How can I access the webcast of Lucira Health's presentation?

The webcast will be available live and archived on Lucira's Events and Presentations page.

What is Lucira Health known for?

Lucira Health is known for developing innovative infectious disease test kits that provide lab-quality molecular testing.

What new diagnostic tests is Lucira Health working on?

Lucira is working on a combined test for COVID-19 and Flu, among other infectious diseases.

Where can I find more information about Lucira Health?

More information can be found on Lucira Health's website at www.lucirahealth.com.